Fair Value Is Coming
RXMD is growing. Its script counts and revenues are increasing, as are its prospects, regardless of what an amateur analysis says.
RXMD sets goals and achieves them.
RXMD plans for the future, including new partnerships, uplisting, and mergers and acquisitions.
RXMD has 3rd-party-audited financials for 2016. How many other penny stocks can say the same?
Fair Value Is Coming